Trial Profile
A phase 2a study of OMS527 in patients with nicotine addiction
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2018
Price :
$35
*
At a glance
- Drugs OMS 527 (Primary)
- Indications Substance-related disorders
- Focus Therapeutic Use
- 04 Jul 2018 New trial record